Heparin Antagonizes Cisplatin Resistance of A2780 Ovarian Cancer Cells by Affecting the WNT Signaling Pathway

Oncotarget - United States
doi 10.18632/oncotarget.18738
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Ellagic Acid and Resveratrol Prevent the Development of Cisplatin Resistance in the Epithelial Ovarian Cancer Cell Line A2780

Journal of Cancer
Oncology
2016English

RNF138 Confers Cisplatin Resistance in Gastric Cancer Cells via Activating Chk1 Signaling Pathway

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2018English

Tubeimoside I Sensitizes Cisplatin in Cisplatin-Resistant Human Ovarian Cancer Cells (A2780/Ddp) Through Down-Regulation of ERK and Up-Regulation of P38 Signaling Pathways

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2011English

Role of Autophagy in Cisplatin Resistance in Ovarian Cancer Cells

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2014English

ABT737 Reverses Cisplatin Resistance by Targeting Glucose Metabolism of Human Ovarian Cancer Cells

International Journal of Oncology
Cancer ResearchOncology
2018English

Mitigating Cisplatin Resistance in Ovarian Cancer.

English

Caveolin-1 Promotes Chemoresistance of Gastric Cancer Cells to Cisplatin by Activating WNT/β-Catenin Pathway

Frontiers in Oncology
Cancer ResearchOncology
2020English

Β-Catenin Signaling Pathway Regulates Cisplatin Resistance in Lung Adenocarcinoma Cells by Upregulating BCL-Xl

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2016English

Cisplatin/Carboplatin Cross-Resistance in Ovarian Cancer

British Journal of Cancer
Cancer ResearchOncology
1989English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy